Diagnostics & Tools December 2020

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

• Philips has agreed to acquire BioTelemetry for $2.8bb
• Verily Life Sciences received a $700mm round of funding
• Everly Well received a $175mm round of funding